Anatara Lifesciences Ltd

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Following the successful licencing of our first product to leading global animal health company, Zoetis Inc, we are now focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

     

Latest Headlines

Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report

🕔2/19/2019 8:21:30 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4D financial report for the half year ending 31st December 2018.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔2/19/2019 8:20:45 AM

Anatara Lifesciences (ASX:ANR) is pleased to release a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will be presenting at the Proactive Investors Australia CEO Sessions and the Wholesale Investor's Emergence 2019 conferences this month.

Read Full Article

News

Anatara Lifesciences Ltd (ASX:ANR) Half Yearly Report

🕔2/19/2019 8:21:30 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4D financial report for the half year ending 31st December 2018.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔2/19/2019 8:20:45 AM

Anatara Lifesciences (ASX:ANR) is pleased to release a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will be presenting at the Proactive Investors Australia CEO Sessions and the Wholesale Investor's Emergence 2019 conferences this month.

Read Full Article

Anatara Life Sciences (ASX:ANR) Investor Presentations Sydney and Melbourne

🕔2/11/2019 1:13:00 PM 1028

This month, Anatara's CEO, Steve Lydeamore will be presenting to investors at events in Sydney and Melbourne. We would like to extend to you the invitation to attend.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Successful proof of concept studies

🕔2/7/2019 11:23:57 AM 1233

Anatara Lifesciences Ltd (ASX:ANR) is pleased to report positive efficacy data from its in vitro Proof of Concept studies of its Gastrointestinal ReProgramming product. GaRP is a unique natural dietary supplement designed to restore and maintain a healthy human gut and microbiome.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report

🕔1/30/2019 11:03:48 AM 1104

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2018. The Company's cash position at the end of the quarter stood at $1.5m. The Company also had $4,500,000 in deposits with terms of greater than 90 days. Expenditure during the quarter was in line with forecast.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Non-Executive Director Appointment

🕔1/23/2019 8:21:56 AM 1464

Anatara Lifesciences (ASX:ANR) is pleased to announce the appointment of Dr. David Brookes as Non-Executive Director and Chair of the Audit and Risk Committee, effective from 23 January 2019.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) PAC Partners Equity Research Report

🕔1/15/2019 12:31:24 PM 1495

PAC Partners Equity Research has released its latest research and valuation report on Anatara Lifesciences (ASX:ANR). The report provided a BUY rating and a 12-month price target of $1.40 per share.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Receives $1.249m R&D Tax Refund

🕔1/14/2019 8:39:28 AM 1462

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $1,249,299 from the Australian Taxation Office under the Federal Government's Research and Development Tax Incentive scheme.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address to Shareholders

🕔11/14/2018 10:20:11 AM 2198

Anatara Lifesciences Ltd (ASX:ANR) provides the Company's Chairman Address to Shareholders.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Chief Executive Officer Appointment

🕔11/14/2018 8:23:04 AM 2040

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has appointed Mr Steven Lydeamore as Chief Executive Officer, effective as of 3rd December 2018.

Read Full Article
###

30,829 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 335) (Last 30 Days: 1412) (Since Published: 30829) 

Markets ASX:ANR

Company Data

    Headquarters
  • 433 Logan Road, Stones Corner
    Brisbane, Queensland 4120
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports

Presentations

Research Report

Quarterly Report

Social Media